Jinhai Medical Technology Limited

SEHK:2225 Stock Report

Market Cap: HK$5.2b

Jinhai Medical Technology Balance Sheet Health

Financial Health criteria checks 4/6

Jinhai Medical Technology has a total shareholder equity of SGD37.5M and total debt of SGD4.7M, which brings its debt-to-equity ratio to 12.6%. Its total assets and total liabilities are SGD62.2M and SGD24.7M respectively.

Key information

12.6%

Debt to equity ratio

S$4.72m

Debt

Interest coverage ration/a
CashS$26.76m
EquityS$37.49m
Total liabilitiesS$24.73m
Total assetsS$62.22m

Recent financial health updates

No updates

Recent updates

Subdued Growth No Barrier To Jinhai Medical Technology Limited (HKG:2225) With Shares Advancing 31%

Mar 17
Subdued Growth No Barrier To Jinhai Medical Technology Limited (HKG:2225) With Shares Advancing 31%

What Jinhai International Group Holdings Limited's (HKG:2225) 50% Share Price Gain Is Not Telling You

Jan 31
What Jinhai International Group Holdings Limited's (HKG:2225) 50% Share Price Gain Is Not Telling You

Here's What's Concerning About Jinhai International Group Holdings' (HKG:2225) Returns On Capital

Jun 06
Here's What's Concerning About Jinhai International Group Holdings' (HKG:2225) Returns On Capital

Be Wary Of Jinhai International Group Holdings (HKG:2225) And Its Returns On Capital

Mar 07
Be Wary Of Jinhai International Group Holdings (HKG:2225) And Its Returns On Capital

Financial Position Analysis

Short Term Liabilities: 2225's short term assets (SGD42.7M) exceed its short term liabilities (SGD21.3M).

Long Term Liabilities: 2225's short term assets (SGD42.7M) exceed its long term liabilities (SGD3.5M).


Debt to Equity History and Analysis

Debt Level: 2225 has more cash than its total debt.

Reducing Debt: 2225's debt to equity ratio has increased from 0% to 12.6% over the past 5 years.

Debt Coverage: 2225's debt is well covered by operating cash flow (39.3%).

Interest Coverage: Insufficient data to determine if 2225's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.